Medutest result on a Hangzhou liraglutide lot lands 4.1 points below the supplier’s figure
A reminder that a purity figure is the output of a method, and that methods differ.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 4 of 4 of this archive, newest first.
A reminder that a purity figure is the output of a method, and that methods differ.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The document is four pages. Three of them are about dates.
Reported from the sessions, and from the two hours afterwards.
Reported from the analysis, not from a warning notice.
Follow the resin, not the catalogue.
The evidence base is thin and the document says so, which is to its credit.
Reported from the sessions, and from the two hours afterwards.
Reported from the analysis, not from a warning notice.
Reported from the sessions, and from the two hours afterwards.
The evidence base is thin and the document says so, which is to its credit.
Reported from the analysis, not from a warning notice.
The observation that closes a facility is rarely the dramatic one.
The evidence base is thin and the document says so, which is to its credit.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Reported from the analysis, not from a warning notice.
A proper account of an operation that existed, and of what closing it cost.
The document is four pages. Three of them are about dates.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Efficacy was never the question in this appraisal. Duration of treatment was.